More on Opko Q1 results

|By:, SA News Editor

OPKO Health (OPK) total revenues: $22.3M (-28.8%); product revenues: $19.8M (+27.7%); operating loss: ($30.3M) (-345.6%); loss/share: ($0.11) (unch); cash & equiv: $156.4M (-15.8%).

4Kscore Test launched through Nashville, TN CLIA lab on March 31.